News
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
6h
Daily Voice on MSNWestchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA DataRegeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...
Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results